These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16839370)

  • 1. Use of fondaparinux in a patient with antiphospholipid antibody syndrome and heparin-associated thrombocytopenia.
    Holtan SG; Knox SK; Tefferi A
    J Thromb Haemost; 2006 Jul; 4(7):1632-4. PubMed ID: 16839370
    [No Abstract]   [Full Text] [Related]  

  • 2. Fondaparinux in acute heparin-induced thrombocytopenia: a case series.
    Goldfarb MJ; Blostein MD
    J Thromb Haemost; 2011 Dec; 9(12):2501-3. PubMed ID: 21883881
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful use of fondaparinux in a child with heparin-induced thrombocytopenia.
    Tokgoz H; Caliskan U; Demir M
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):769-71. PubMed ID: 22964766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
    Seculini Patiño CE; Pascualini MF; Tabares AH
    Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fondaparinux as an alternative anticoagulant in heparin-induced thrombocytopenia in the patient with a ventricular assist device].
    Cegarra-Sanmartín V; Paniagua P; Galán J; Muñoz C; Moral MV
    Rev Esp Anestesiol Reanim; 2013 Nov; 60(9):531-4. PubMed ID: 23153592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of heparin-induced thrombocytopenia after cardiac surgery: preliminary experience with fondaparinux.
    Pappalardo F; Scandroglio A; Maj G; Zangrillo A; D'Angelo A
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):790-2. PubMed ID: 19660283
    [No Abstract]   [Full Text] [Related]  

  • 7. Voting with your fondaparinux.
    Warkentin TE
    Thromb Res; 2014 Jul; 134(1):3-4. PubMed ID: 24787988
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia successfully treated with fondaparinux.
    Seldrum S; Lambert M; Hainaut P
    Acta Clin Belg; 2009; 64(2):144-6. PubMed ID: 19432027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can heparin-induced thrombocytopenia be associated with fondaparinux use? A rebuttal.
    Elalamy I; Tribout B
    J Thromb Haemost; 2008 Jul; 6(7):1242-3; author reply 1243-6. PubMed ID: 19330935
    [No Abstract]   [Full Text] [Related]  

  • 10. Fondaparinux (Arixtra(R)), a safe alternative for the treatment of patients with heparin-induced thrombocytopenia?
    Badger NO
    J Pharm Pract; 2010 Jun; 23(3):235-8. PubMed ID: 21507819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic considerations in the management of patients with heparin-induced thrombocytopenia.
    Tong LM; Mendez MN
    Prog Cardiovasc Nurs; 2002; 17(3):142-7. PubMed ID: 12091763
    [No Abstract]   [Full Text] [Related]  

  • 12. Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report.
    He Y; He H; Liu D; Long Y; Su L; Cheng W
    Medicine (Baltimore); 2018 Sep; 97(37):e12236. PubMed ID: 30212955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How we manage patients with heparin induced thrombocytopenia.
    Scully M; Gates C; Neave L
    Br J Haematol; 2016 Jul; 174(1):9-15. PubMed ID: 27097741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
    Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
    Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of unsuccessful treatment of heparin-induced thrombocytopenia (HIT) with fondaparinux.
    Miranda AC; Donovan JL; Tran MT; Gore JM
    J Thromb Thrombolysis; 2012 Jan; 33(1):133-5. PubMed ID: 21947717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin.
    Al-Rossaies A; Alkharfy KM; Al-Ayoubi F; Al-Momen A
    Int J Clin Pharm; 2011 Dec; 33(6):997-1001. PubMed ID: 22002684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.
    Warkentin TE; Pai M; Sheppard JI; Schulman S; Spyropoulos AC; Eikelboom JW
    J Thromb Haemost; 2011 Dec; 9(12):2389-96. PubMed ID: 21883878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia.
    Snodgrass MN; Shields J; Rai H
    Clin Appl Thromb Hemost; 2016 Nov; 22(8):712-717. PubMed ID: 27179015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.
    Efird LE; Kockler DR
    Ann Pharmacother; 2006; 40(7-8):1383-7. PubMed ID: 16788093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study.
    Kang M; Alahmadi M; Sawh S; Kovacs MJ; Lazo-Langner A
    Blood; 2015 Feb; 125(6):924-9. PubMed ID: 25515959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.